Supraventricular tachycardias are a cause of significant morbidity in children. Newer anti-arrhythmic drugs and the invention of radiofrequency catheter ablation have revolutionised anti-arrhythmic therapy in children.
Conclusion: With the availability of these very effective therapeutic options, an improved knowledge of these methods and their indications is required.